Lege Artis Medicinae

[Comment]

WITTMANN István

MAY 20, 2011

Lege Artis Medicinae - 2011;21(05)

COMMENTS

0 comments

Further articles in this publication

Lege Artis Medicinae

[The place of sulphonylurea compounds in the blood glucose lowering therapy of type 2 diabetes]

WINKLER Gábor

[The mechanism of blood glucose lowering action of sulphonylureas, their advantages and potencial risks are overviewd in the article. The author delineates the present place of the sulphonylurea group in the antihyperglycemic therapy of type 2 diabetes, listing possibilities of monotherapeutic as well as combined applications. It is emphasized that traditional insulin-secretagogue compounds have their place in the therapy of type 2 diabetes even beside of the new, incretin-type secretagogues.]

Lege Artis Medicinae

[Increasing patient safety in anaesthesiology and intensive care with the prevention of medical errors]

BOGÁR Lajos

Lege Artis Medicinae

[A new fix combination therapy in effective cardiovascular prevention]

NAGY András Csaba

[A large amount of literature is available one modern antihypertensive therapy. The experiences of the past 10-20 years have changed clinical practice in many areas of medication and of prevention of complications. Therapy has been revolutionised not only by the new and newer agents but also by the introduction of combined therapy. In this paper, we discuss the use of a new fix-combination antihypertensive drug, with two components (telmisartan and amlodipine) about which excellent evidence is available. We highlight the advantages of this combination therapy in cardiovascular prevention, which is partly explained by better patient compliance due to its favourable side-effect profile.]

Lege Artis Medicinae

[Correspondence – Advances in Anticoagulation Over the Past Two Decades]

BLASKÓ György, SAS Géza

Lege Artis Medicinae

[Relationship Networks]

BUDA Béla

All articles in the issue